ORCHPHARMA logo

Orchid Pharma Stock Price

Symbol: NSEI:ORCHPHARMAMarket Cap: ₹38.5bCategory: Pharmaceuticals & Biotech

ORCHPHARMA Share Price Performance

₹754.90
-644.80 (-46.07%)
24.6% undervalued intrinsic discount
₹1,000.67
Fair Value
₹754.90
-644.80 (-46.07%)
24.6% undervalued intrinsic discount
₹1,000.67
Fair Value
Price ₹754.90
AnalystConsensusTarget ₹1,000.67

ORCHPHARMA Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value ₹1.00k 24.6% undervalued intrinsic discount

US Partnership For Enmetazobactam Will Unlock Significant Market Opportunities

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative

Recent ORCHPHARMA News & Updates

No updates

Orchid Pharma Limited Key Details

₹9.2b

Revenue

₹5.4b

Cost of Revenue

₹3.8b

Gross Profit

₹2.8b

Other Expenses

₹996.6m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 12, 2025
Earnings per share (EPS)
19.65
Gross Margin
40.97%
Net Profit Margin
10.81%
Debt/Equity Ratio
13.7%

Orchid Pharma Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About ORCHPHARMA

Founded
1992
Employees
871
CEO
Manish Dhanuka
WebsiteView website
www.orchidpharma.com

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company has multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is based in Narsinghpur, India. Orchid Pharma Limited operates as a subsidiary of Dhanuka Laboratories Limited.

Indian Market Performance

  • 7 Days: -1.1%
  • 3 Months: 5.6%
  • 1 Year: -4.1%
  • Year to Date: -2.0%
Over the last 7 days, the market has dropped 1.1%, driven by declines in every sector, especially the Healthcare sector. As for last year, the market is also down 4.1%. Earnings are forecast to grow by 16% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading